ADVICENNE

- EUR (-)

- 15 min delayed data - Euronext Paris

Open:	-
Change:	-
Volume:	-

Low:	-
High:	-
High / Low range:	-

Type:	Stocks
Ticker:	ALDVI
ISIN:	FR0013296746

ADVICENNE overview

> News Business Wire published a news.

Advicenne Reaches a Significant Milestone With the US FDA in the Development of ADV7103 in Cystinuria • • Business Wire • Stocks • More ADVICENNE news...

Regulatory News: Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, provides an update on recent exchanges with the U.S. FDA (Food and Drug Administration) about the development of ADV7103 in cystinuria, and announces that it has reached an important milestone. As previously stated, the company has engaged in a new round of discussions...

Thank you Chart

> News Business Wire published a news.

Advicenne Announces 2024 Gross Sales1 • • Business Wire • Stocks • More ADVICENNE news...

Regulatory News: Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, today announces that gross sales reached €4.8 million for the 2024 financial year, up 9.2% on the previous year. Gross sales do not include royalties from partners on sales in their respective territories, estimated at €0.5 million for 2024. Sibnayal® mostly drove...

Thank you Chart

> News Business Wire published a news.

Advicenne Finalizes Agreement with Primex Pharmaceuticals AG • • Business Wire • Stocks • More ADVICENNE news...

Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, today announced the conclusion of an agreement with Primex Pharmaceuticals AG, a Swiss biopharmaceutical company. This agreement finalizes the restructuring of contracts signed in 2016. Under this agreement, Advicenne will receive 3.5 million euros, half of which will...

Thank you Chart

> News Business Wire published a news.

Advicenne Announces its 2025 Financial Calendar • • Business Wire • Stocks • More ADVICENNE news...

Regulatory News: Advicenne (Euronext Growth Paris ALDVI - FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare renal diseases, announces its 2025 financial communication calendar. Event Date* 2024 sales release January 23, 2025 2024 annual financial statement March 27, 2025 AGM May 15, 2025 2025 First Half financial statement September 18, 2024 *: subject to change. End of trading About...

Thank you Chart

> Analyses

Londinia AI has published a new analysis for pierrott.

0
91749
15636
0

ADVICENNE - Daily

Timeframe : Daily - Simple chart
Status : TARGET REACHED

Has the basic bearish trend slowed or is it lacking in power? The short term does not yet offer any information that would allow us to anticipate a recovery in the bearish trend or a rebound. Sellers'…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis for pierrott.

0
91749
15636
0

ADVICENNE - Daily

Timeframe : Daily - Simple chart
Status : TARGET REACHED

We are currently in a phase of short-term indecision. In a case like this, you could favour trades in the direction of the basic trend on ADVICENNE. As long as you are under the resistance located at…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis for pierrott.

0
91749
15636
0

ADVICENNE - Weekly

Timeframe : Weekly - Simple chart
Status : TARGET REACHED

The bearish trend is currently very strong for ADVICENNE. As long as the price remains below the resistance at 1.380 EUR, you could try to take advantage of the bearish rally. The first bearish…

Thank you Reply Chart

> Analyses

Londinia AI has published a new analysis for pierrott.

0
91749
15636
0

ADVICENNE - 15 min.

Timeframe : 15 min. - Simple chart
Status : TARGET REACHED

All elements being clearly bearish, it would be possible for traders to trade only short positions (for sale) on ADVICENNE as long as the price remains well below 2.328 EUR. The sellers' bearish…

Thank you Reply Chart

Load more content